Inhalation Sciences Sweden AB (XSAT:ISAB) Margin of Safety % (DCF Dividends Based): N/A (As of Jul. 13, 2026)


XSAT:ISAB Inhalation Sciences Sweden AB XSAT:ISAB
29 GF Score
Price kr0.22
GF Value kr0.39
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Inhalation Sciences Sweden AB Margin of Safety % (DCF Dividends Based)?

Margin of Safety % (DCF Dividends Based) = (Intrinsic Value: DCF (Dividends Based) - Current Price) / Intrinsic Value: DCF (Dividends Based).

Note: Discounted Dividend model is only suitable for companies who have a consistant distribution history with more than 5 years. If the company's dividends does not remain steady over a long period, results may not be accurate due to the low consistency. The model is also only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, the data will not be stored into our database.

Inhalation Sciences Sweden AB's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Dividends Based) is not calculated.

XSAT:ISAB vs ABT, SYK, MDT: Margin of Safety % (DCF Dividends Based) Comparison

For the Medical Devices subindustry, Inhalation Sciences Sweden AB's Margin of Safety % (DCF Dividends Based), along with its competitors' market caps and Margin of Safety % (DCF Dividends Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Inhalation Sciences Sweden AB Margin of Safety % (DCF Dividends Based) vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Inhalation Sciences Sweden AB's Margin of Safety % (DCF Dividends Based) distribution charts can be found below:

* The bar in red indicates where Inhalation Sciences Sweden AB's Margin of Safety % (DCF Dividends Based) falls into.


XSAT:ISAB
29GF Score
Inhalation Sciences Sweden AB XSAT:ISAB
Margin of Safety % (DCF Dividends Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Inhalation Sciences Sweden AB (XSAT:ISAB) Overvalued in 2026?

Based on GuruFocus' analysis, Inhalation Sciences Sweden AB stock appears to be undervalued. The current stock price of kr0.22 is trading 42.8% below its estimated GF Value™ of kr0.39. GuruFocus considers Inhalation Sciences Sweden AB to be Possible Value Trap.

Key valuation signals for XSAT:ISAB:

  • Margin of Safety % (DCF Dividends Based): N/A
  • GF Value™: kr0.39 vs. price of kr0.22 (42.8% below fair value)
  • GF Score™: 29/100 with 5 warning signs

No single metric tells the full story. See the XSAT:ISAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Inhalation Sciences Sweden AB Business Description

Address Halsovagen 7, Huddinge, SWE, 141 57
Inhalation Sciences Sweden AB develops and commercializes patented lab instrument for inhalation research. Its products include PreciseInhale an advanced laboratory system used to measure inhaled particles and their effect on lungs, and LaminarPace tool for drying small amounts of the drug substance.
29GF Score

Get the complete analysis for XSAT:ISAB

Margin of Safety % (DCF Dividends Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.22
Price
kr0.39
GF Value